Anticancer Therapeutic Strategies Based on CDK Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|30|5327-5332

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.30, 2013-09, pp. : 5327-5332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of CDK5 inhibitors to promote corneal epithelial wound healing

By Zelenka Peggy S   Smith Janine  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 875-887

Informa Healthcare

Access to resources Recommend Favorite

Skp2 Inhibitors: Novel Anticancer Strategies

By  

Current Medicinal Chemistry, Vol. 23, Iss. 22, 2016-08 ,pp. : 2363-2379

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibitors as Therapeutic Agents: Current and Future Strategies

By  

Current Medicinal Chemistry, Vol. 10, Iss. 6, 2003-03 ,pp. : 479-503

Bentham Science Publishers

Access to resources Recommend Favorite

RNA-based therapeutic strategies for cancer

By Read Martin L   Stevenson Mark   Farrow Paul J   Barrett Lee B   Seymour Leonard W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. : 627-638

Informa Healthcare

Access to resources Recommend Favorite